Abstract:BACKGROUND Giant congenital biliary dilation (CBD) is a rare condition observed in clinical practice. Infants born with this condition often experience a poor overall health status, and the disease progresses rapidly, leading to severe biliary obstruction, infections, pressure exerted by the enlarged CBD on abdominal organs, disturbances in the internal environment, and multiple organ dysfunction. The treatment of giant CBD using laparoscopy is challenging due to the high degree of variation in the shape of the bile duct and other organs, making it difficult to separate the bile duct wall from adjacent tissues or to control bleeding. CASE SUMMARY Herein, we present the details of an 11-d-old male newborn who was diagnosed with giant CBD. The patient was admitted to the neonatal surgery department of our hospital due to a history of common bile duct cyst that was detected more than 3 mo ago, and also because the patient had been experiencing yellowish skin for the past 9 d. The abnormal echo in the fetal abdomen was first noticed by the patient’s mother during a routine ultrasound examination at a local hospital, when the patient was at 24 wk + 6 d of pregnancy. This finding raised concerns about the possibility of congenital biliary dilatation (22 mm × 21 mm). Subsequent ultrasound examinations at different hospitals consistently confirmed the presence of a congenital biliary dilatation. No specific treatment was administered for biliary dilatation during this period. A computed tomography scan conducted during the hospitalization revealed a large cystic mass in the right upper quadrant and pelvis, measuring approximately 9.2 cm × 7.4 cm × 11.3 cm. Based on the scan, it was classified as a type I biliary dilatation. CONCLUSION The analysis reveals that prenatal imaging techniques, such as ultrasound and magnetic resonance imaging, play a crucial role in the early diagnosis, fetal prognosis, and treatment plan for giant CBD. Laparoscopic surgery for giant CBD presents certain challenges, including difficulties in separating the cyst wall, anastomosis, and hemostasis, as well as severe biliary system infection and ulceration. Consequently, there is a high likelihood of converting to laparotomy. The choice between surgical methods like hepaticojejunostomy (HJ) or hepaticoduodenostomy has not been standardized yet. However, we have achieved favorable outcomes using HJ. Preoperative management of inflammation, biliary drainage, liver function protection, and supportive treatment are particularly vital in improving children’s prognosis. After discharge, it is essential to conduct timely reexamination and close follow-up to identify potential complications.

Nephromegaly and Elevated Hepatocyte Growth Factor in Children with Biliary Atresia.

Nephromegaly and Elevated Plasma Hepatocyte Growth Factor[ndash ]transforming Growth Factor-[Beta ]1 Ratio in Infants with Fulminant Hepatitis or Biliary Atresia

Serum TGF-β1 and VEGF Levels Reflect the Liver Hardness and Function in Children with Biliary Atresia

Regulation of bile acid metabolism in biliary atresia: reduction of FGF19 by Kasai portoenterostomy and possible relation to early outcome

Low Gamma-Glutamyl Transpeptidase Levels at Presentation Are Associated with Severity of Liver Illness and Poor Outcome in Biliary Atresia.

Clinical analysis of childhood acute lymphoblastic leukemia with nephromegaly at onset

Calreticulin Expression Is Associated With Gamma-Glutamyl Transferase And Intercellular Cell Adhesion Molecule-1 In Biliary Atresia

Upregulation of High Mobility Group Box 1 May Contribute to the Pathogenesis of Biliary Atresia.

Metabonomics Reveals Metabolite Changes in Biliary Atresia Infants

Hepatocellular telomere length in biliary atresia measured by Q-FISH

Nephrocalcinosis and Kidney Function in Children and Adults with X-linked Hypophosphatemia: Baseline Results from a Large Longitudinal Study

Potential therapeutic target of EGF on bile duct ligation model and biliary atresia children

Bile acid profiles in adult patients with biliary atresia who achieve native liver survival after portoenterostomy

Amyloid precursor protein as a fibrosis marker in infants with biliary atresia

Association of Gut Microbiota and Metabolites With Disease Progression in Children With Biliary Atresia

Expression of activin A in liver tissue and the outcome of patients with biliary atresia

Progress in Biomarkers Related to Biliary Atresia

Hyperuricemia Is an Early and Relatively Common Feature in Children with HNF1B Nephropathy but Its Utility as a Predictor of the Disease Is Limited

Giant bile duct dilatation in newborn: A case report

Biliary Atresia: Clinical and Research Challenges for the Twenty-First Century

Subclinical cardiac abnormalities in children with biliary atresia correlate with outcomes after liver transplantation